Assignee
TARGETED GENETICS CORP
US·18 granted patents·4 pending applications·2,773 citations·filing 1994–2007
Top patents by PatentIndex Score
22 records- 0198US7125717B2Metabolically activated recombinant viral vectors and methods for their preparation and useTARGETED GENETICS CORP·Filed 2003·Granted Oct 24, 2006·360 cites·20 claims
- 0298US6596535B1Metabolically activated recombinant viral vectors and methods for the preparation and useTARGETED GENETICS CORP·Filed 2000·Granted Jul 22, 2003·426 cites·29 claims
- 0397US5658776AGeneration of high titers of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1995·Granted Aug 19, 1997·529 cites·15 claims
- 0496US6995006B2Methods for generating high titer helper-free preparations of released recombinant AAV vectorsTARGETED GENETICS CORP·Filed 2001·Granted Feb 7, 2006·176 cites·53 claims
- 0596US6989264B2Methods for generating high titer helper-free preparations of released recombinant AAV vectorsTARGETED GENETICS CORP·Filed 2001·Granted Jan 24, 2006·187 cites·81 claims
- 0696US6566118B1Methods for generating high titer helper-free preparations of released recombinant AAV vectorsTARGETED GENETICS CORP·Filed 2000·Granted May 20, 2003·489 cites·41 claims
- 0795US6936466B2Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectorsTARGETED GENETICS CORP·Filed 2001·Granted Aug 30, 2005·47 cites·109 claims
- 0895US6924128B2Packaging cell lines for generation of high titers of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 2000·Granted Aug 2, 2005·53 cites·22 claims
- 0993US6537540B1Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disordersTARGETED GENETICS CORP·Filed 2000·Granted Mar 25, 2003·97 cites·16 claims
- 1088US6893865B1Methods, compositions, and cells for encapsidating recombinant vectors in AAV particlesTARGETED GENETICS CORP·Filed 2000·Granted May 17, 2005·48 cites·18 claims
- 1186US6642051B1Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1998·Granted Nov 4, 2003·83 cites·24 claims
- 1286US6346415B1Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1998·Granted Feb 12, 2002·40 cites·35 claims
- 1382US6316257B1Modified rapid expansion methods (“modified-REM”) for in vitro propagation of T lymphocytesTARGETED GENETICS CORP·Filed 1997·Granted Nov 13, 2001·57 cites·26 claims
- 1480US5736387AEnvelope fusion vectors for use in gene deliveryTARGETED GENETICS CORP·Filed 1995·Granted Apr 7, 1998·60 cites·27 claims
- 1578US6083751AChimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cellsTARGETED GENETICS CORP·Filed 1995·Granted Jul 4, 2000·56 cites·12 claims
- 1674US6541258B2AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1997·Granted Apr 1, 2003·40 cites·21 claims
- 1772US5874556AHybrid genes for use in the production of TH -independent cytotoxic T cellsTARGETED GENETICS CORP·Filed 1994·Granted Feb 23, 1999·25 cites·18 claims
- 1858US2008175845A1Methods for treating target joints in inflammatory arthritis using AAV vectors encoding a TNF antagonistTARGETED GENETICS CORP·Filed 2007·Application pending·0 cites
- 1955US2008249050A1Compounds and methods to enhance rAAV transductionTARGETED GENETICS CORP·Filed 2007·Application pending·0 cites
- 2051US2005164387A1Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytesTARGETED GENETICS CORP·Filed 2005·Application pending·0 cites
- 2146US2006166318A1Methods, compositions, and cells for encapsidating recombinant vectors in AAV particlesTARGETED GENETICS CORP·Filed 2005·Application pending·0 cites
- 2232US6593124B1Hybrid genes for expression of stimulatory factors in activated T cellsTARGETED GENETICS CORP·Filed 1998·Granted Jul 15, 2003·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when TARGETED GENETICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →